Major UK project launched to tackle drug-resistant superbugs with AI

The UK is to use artificial intelligence (AI) to tackle the rising numbers of infections that have become resistant to treatment. The project - a collaboration between the Fleming Initiative and the pharmaceutical company GSK - is a battle between superbugs and supercomputers. It aims to speed up the discovery of fresh antibiotics and deliver new ways of killing other threats, including deadly fungal infections. Overusing antibiotics drives bacteria to evolve resistance to infections, which means new drugs are a priority. Drug-resistant infections are a growing problem - one known as the silent pandemic.